Register
Forgot your password?

Long-term results of balloon catheter mitralvalvuloplasty through 14 and 22 years(clinical cases and review)

Authors: L.S. Kokov 1, 3, A.N. Korostelev 2, M.V. Il'ina 2, M.V. Parkhomenko 1, 3, N.M. Bikbova 3, E.V. Kovaleva 3

Company: 1N.V. Sklifosovsky Research Institute for Emergency Medicine of Moscow Department of Health Bol'shaya Sukharevskaya ploshchad', 3, Moscow 129090, Russian Federation;
 2 A.V. Vishnevsky Institute of Surgery of Ministry of Health of the Russian Federation, Bol’shaya Serpukhovskaya ulitsa, 27, Moscow, 117997, Russian Federation;
 3 I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Bol'shaya Pirogovskaya ulitsa, 2–4, Moscow, 119991, Russian Federation

For correspondence:  Sign in or register.


DOI: https://doi.org/10.24022/1997-3187-2017-11-4-376-384

For citation: Kokov L.S., Korostelev A.N., Il'ina M.V., Parkhomenko M.V., Bikbova N.M., Kovaleva E.V. Long-term results of balloon catheter mitral valvuloplasty through 14 and 22 years (clinical cases and review). Kreativnaya Kardiologiya (Creative Cardiology). 2017; 11 (4): 376–84 (in Russ.). DOI: 10.24022/1997-3187-2017-11-4-376-384

Received / Accepted:  02.06.2017/27.06.2017

Keywords: mitral stenosis primary/recurrent catheter balloon mitral valvuloplasty Inoue balloon catheter

Download
Full text:  

 

Abstract

Two patients with rheumatic mitral stenosis were observed after 14 and 22 years since primary PMV. Patient 1 (22 years after PMV) had been underwent the percutaneous transluminal coronary angioplasty (PTCA) due to ischemic heart disease, the second one (14 years after primary PMV) had been underwent redo PMV due to severe mitral valve restenosis. Patient 1: MVO area was increased from 1.4 cm2 up to 4.2 cm2 after the primary PMV. 22 years since that MVO area was 1.9 cm2, MV peak pressure gradient – 14 mm Hg, mean pressure gradient (MPG) – 14 mm Hg. Patient 2: MVO area was increased from 0.68 cm2 to 1.6 cm2 after the primary PMV. 14 years since that MVO was 1.35 cm2. PMV was performed again. MVO had been increased up to 2.51 cm2 with the decreasing of MPG on MV from 12.29 to 2.9 mm Hg. Four years later, redo PMV: MVO – 2.4 cm2, MPG – 3.4 mm Hg, mild mitral regurgitation, pulmonary artery systolic pressure – 26 mm Hg. PMV is a minimally invasive and efficacy method of the mitral stenosis therapy in long-term period (up to 22 years). Echo should be performed every 1–2 years after PMV. In case of mitral restenosis the redo PMV is possible and the result will be able appropriate.

References

  1. Rifaie O., Abdel-Dayem M.K., Ramzy A. et al. Percutaneous mitral valvotomy versus cloused mitral commissurotomy. Up to 15 years of followup of prospective randomized study. J. Cardiol. 2009; 53: 28–34.

  2. Song J.K., Song J.M., Kang J.H. et al. Restenosis and adverse clinical events after successful percutaneous mitral valvuloplasty: immediate post-procedural mitral valve area as an impotent prognosticator. Eur. Heart J. 2009; 30: 1254–62.

  3. Vahanian A., Alfiery O., Andreotti F. et al. Guidelines on the management of valvular heart disease (version 2012): The joint task force on the management of valvular heart disease of the European Society of cardiology and European association for cardio-thoracic surgery. Eur. Heart J. 2012; 33: 2451–96.

  4. Sharma K.H., Jain S., Shukla A. et al. Patient profile and results of percutaneous transvenous mitral commissurotomy in mitral stenosis following prior percutaneous transvenous mitral commissurotomy vs surgical commissurotomy. Indian Heart J. 2014; 66 (2): 164–8.

  5. Silin V.A., Suкhov V.K. The treatment of mitral stenosis by balloon dilatation. Grudnaya i Serdechno-Sosudistaya Khirurgiya (Russian Journal of Thoracic and Cardiovascular Surgery). 1990; 4: 8–12 (in Russ.).

  6. Volynskiy Yu.D., Kokov L.S., Goryanina N.K. Percutaneous transcatheter double balloon valvuloplasty in mitral stenosis. Khirurgiya (Surgery). 1989; 3: 153–4 (in Russ.).

  7. Kokov L.S., Shakhov B.E., Sukhov V.K. Endovascular treatmentof rheumatic heart disease (twenty years of domestic practice). Diagnosticheskaya i Interventsionnaya Radiologiya (Diagnostic and Interventional Radiology). 2008; 2 (4): 77–86 (in Russ.).

  8. Song J.K., Kim M.J., Yun S.C. et al. Long-term outcomes of of percutaneous mitral balloon valvuloplasty versus open cardiac surgery. J. Thorac. Cardiovasc. Surg. 2010; 131 (1): 103–10.

  9. Coutincho G.F., Branco C.F., Jorger J. et al. Mitral valve surgery after percutaneous mitral commissurotomy: is repair still feasible? Eur. J. Cardiothorac. Surg. 2015; 47 (1): e1–6.

  10. Kang D.H., Lee C.H., Kim D.H. et al. Early percutaneous mitral commissurotomy vs. conventional management in asymptomatic moderate mitral stenosis. Eur. Heart J. 2012; 33 (12): 1511–7.

  11. Wang A., Krasuski R.A., Warner J.J. et al. Serial echocardiographic evaluation of restenosis after successful percutaneous mitral commissurotomy. J. Am. Coll. Cardiol. 2002; 39: 328–34.

  12. Palacios I.F., Sanchez P.L., Harrel L.C. et al. Which patients benefits from percutaneous balloon mitral valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation. 2002; 105: 1465–71.

  13. Ben-Farhat M., Betbout F., Gamra H. et al.Predictors of long-term event-free survival and of freedom restenosis after percutaneous balloon mitral commissurotomy. Am. Heart J. 2001; 142: 1072–9.

  14. Chen C.R., Cheng T.O., Chen J.Y. et al. Long term results of percutaneous mitral valvuloplasty with the INOUE balloon catheter. Am. J. Cardiol. 1992; 70: 1445–8.

  15. Fawzy M.E. Long-term results up to 19 years of mitral balloon valvulopasty. Asian Cardiovasc. Thorac. Ann. 2009; 17: 627–33.

  16. Bouleti C., Lung B., Laouenan D. et al. Late results of percutaneous mitral commissurotomy up to 20 years: development and validation of risk score predicting late functional results from a series of 912 patients. Circulation. 2012; 1; 125 (17): 2119–27.

  17. Wilkins G.T., Weyman A.E., Abascal V.M. et al. Percutaneous mitral valvulotomy: an analisis of echocardiographic variables related to outcome and the mechanism of dilatation. Br. Heart J. 1988; 60: 299–308.

  18. Nunes M.C.P., Tan T.C., Elmariah S. et al. The echo score revisited: impact of incorporating commissural morphology and leaflet displacement to the prediction of outcome for patients undergoing percutaneous mitral valvuloplasty. Circulation. 2014; 129: 886–95.

  19. Sial J.A., Farman M.T., Saghir T. Zaman K.S. Percutaneous transvenous mitral commissurotomy and percutaneous coronary intervention successfully applied in one patient in same sitting. Pak. Med. Assoc. 2011; 61 (1): 90–2.

  20. Ostovan M., Askani A., Abounajmis S. Razazi V. Mitral valve restenosis after percutaneous transmitral valvuloplasty, role of continuous inflammation. J. Cardiovasc. Thorac. Surg. 2014; 6 (3): 191–5.

  21. Shaw T.R., Sutaria N., Prendergast B. Clinical and haemodynamic profiles of young, middle aged, and elderly patients with mitral stenosis undergoing mitral balloon valvulotomy. Heart. 2003; 89: 1430–6.

  22. Cruz-Gonsalez I., Sanchez-Ledwsma M., Sanshez P.L. et al. Predicting success and long-term outcomes of percutaneous mitral valvuloplasty: a multifactorial score. Am. J. Med. 2009; 122: 581.e11–9.

  23. Bouleti C., Lung B., Himbert D. et al. Relationship between valve calcification and longterm results of percutaneous mitral commissurotomy for rheumatic mitral stenosis. Circ. Cardiovasc. Interv. 2014; 7: 381–9.

  24. Dreyfus J., Cimadevilla C., Nguyen V. et al. Feasibility of percutaneous mitral commissurotomy in patients with commissural mitral valve calcification. Eur. Heart J. 2014; 35: 1617–23.

  25. Sutaria N., Shaw T.R., Prendegast B. Northridge D. Transoesophageal echocardiography assessment of mitral valve commissural morphology predicts outcome after balloon mitral valvulotomy. Heart. 2006; 92: 52–7.

  26. Chmielak Z., Kruk M., Demkow M. et al. Longterm follow-up of patients with percutaneous mitral commissurotomy. Kardiol. Pol. 2008; 66 (5): 525–30; disc.: 531–2.

  27. Bouleti C., Lung B., Himbert D. et al. Reinterventions after percutaneous mitral commissurotomy during long-term follow-up, up to 20 years: the role of repeat percutaneous mitral commissurotomy. Tur. Heart J. 2013; 34: 1923–30.

  28. Rifaie O., Esmat I., Nammas W. Immediate and long-term outcome of redo percutaneous mitral valvuloplasty: comparison with initial procedure in patients with rheumatic mitral restenosis. J. Interv. Cardiol. 2010; 23 (1): 1–6.

About Authors

  • Kokov Leonid Sergeevich, Dr Med. Sc., Professor, Corresponding Member of Russian Academy of Sciences, scientific Chief of department for interventional of N.V. Sklifosovsky Research Institute for Emergency Medicine, Chief of Chair Radiological Diagnosis of I.M. Sechenov First Moscow State Medical University;
  • Korostelev Aleksandr Nikolaevich, Dr Med. Sc., Professor, Chief Researcher;
  • Il'ina Mariya Viktorovna, Cand. Med. Sc., Senior Researcher;
  • Parkhomenko Mstislav Vasil'evich, chief of department for interventional radiology of N.V. Sklifosovsky Research Institute for Emergency Medicine, assistant of the Chair of Radiological Diagnosis of I.M. Sechenov First Moscow State Medical University;
  • Bikbova Nataliya Marsovna, Researcher; Kovaleva Elena Valentinovna, Dr Med. Sc., Head of Department

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by